open access

Vol 13, No 1 (2017)
Case report
Published online: 2017-07-21
Get Citation

Oesophageal cancer — case report and literature review

Marek Kowalczyk1, Michał Piątek, Dorota Imielska Zdunek, Agnieszka Boratyn-Nowicka
DOI: 10.5603/OCP.2017.0005
·
Oncol Clin Pract 2017;13(1):30-33.


Affiliations

  1. Department of Clinical Oncology, University Clinical Centre named after Prof. K. Gibiński in Katowice, Poland

open access

Vol 13, No 1 (2017)
CASE REPORT
Published online: 2017-07-21

Abstract

Based on the case report in this article, the different means of effective treatment, both causative and palliative, including available therapeutic modalities (radio-chemotherapy, chemotherapy) of locally advanced and subsequently metastatic squamous cell carcinoma of the cervical oesophagus, are presented. Despite a very long period between diagnosis and initiation of the treatment, satisfactory disease control and overall survival were achieved.

Abstract

Based on the case report in this article, the different means of effective treatment, both causative and palliative, including available therapeutic modalities (radio-chemotherapy, chemotherapy) of locally advanced and subsequently metastatic squamous cell carcinoma of the cervical oesophagus, are presented. Despite a very long period between diagnosis and initiation of the treatment, satisfactory disease control and overall survival were achieved.

Get Citation

Keywords

squamous cell carcinoma of the cervical oesophagus, management strategy, available therapeutic modalities (radio-chemotherapy, chemotherapy)

About this article
Title

Oesophageal cancer — case report and literature review

Journal

Oncology in Clinical Practice

Issue

Vol 13, No 1 (2017)

Article type

Case report

Pages

30-33

Published online

2017-07-21

DOI

10.5603/OCP.2017.0005

Bibliographic record

Oncol Clin Pract 2017;13(1):30-33.

Keywords

squamous cell carcinoma of the cervical oesophagus
management strategy
available therapeutic modalities (radio-chemotherapy
chemotherapy)

Authors

Marek Kowalczyk
Michał Piątek
Dorota Imielska Zdunek
Agnieszka Boratyn-Nowicka

References (12)
  1. Wojciechowska U, Didkowska J. Zachorowania i zgony na nowotwory złośliwe w Polsce. Krajowy Rejestr Nowotworów, Centrum Onkologii — Instytut im. Marii Skłodowskiej-Curie. Available on http://onkologia.org. pl/raporty/last access on 22. ; 05: 2017.
  2. Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013; 381(9864): 400–412.
  3. Bedenne L, Michel P, Bouché O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007; 25(10): 1160–1168.
  4. Gaast AV, Hagen Pv, Hulshof M, et al. Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from a multicenter randomized phase III study. Journal of Clinical Oncology. 2010; 28(15_suppl): 4004–4004.
  5. Sjoquist KM, Burmeister BH, Smithers BM, et al. Australasian Gastro-Intestinal Trials Group, Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007; 8(3): 226–234.
  6. Jin HL, Zhu H, Ling TS, et al. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroenterol. 2009; 15(47): 5983–5991.
  7. Akutsu, Y. & Matsubara, H. Chemoradiotherapy and surgery for T4 esophageal cancer in Japan Surg Today. 2015; 45: 1360.
  8. Sabra MJ, Smotherman C, Kraemer DF, et al. The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons national surgical quality improvement program (ACS-NSQIP) 2005-2012. J Surg Oncol. 2017; 115(3): 296–300.
  9. Schreiber D, Rineer J, Vongtama D, et al. Impact of postoperative radiation after esophagectomy for esophageal cancer. J Thorac Oncol. 2010; 5(2): 244–250.
  10. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001; 345(10): 725–730.
  11. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005; 23(10): 2310–2317.
  12. Homs MYV, v d Gaast A, Siersema PD, et al. Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction. Cochrane Database Syst Rev. 2006(4): CD004063.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl